Health Care Cost

Margaret E. O'Kane, president of the National Committee for Quality Assurance will join The American Journal of Managed Care for a Tweetchat on June 26 at 1 pm EST. Follow the discussion and ask your own questions using #AJMCchat.

Among the 20 chronic conditions with the highest impact on the Medicare population, some have no quality measure, which limits Medicare's ability to pay for value.

Concepts from the patient-centered medical home model can offer answers to giving the newly insured a place to find care outside of the emergency department setting.

Aledade, founded by Farzard Mostashari, MD, announced on Monday that it had raised $30 million to support its mission of partnering with independent primary care physicians to create accountable care organizations and further fuel the company's growth.

Integrating behavioral health care into the space where care for diabetes occurs can be aided by new delivery models and by technology, panelists say.

Arkansas has implemented multi-payer payment reform incorporating both episodic and Patient-Centered Medical Home models. Early perceptions of a sample of stakeholders were largely positive to date.

Multiple factors can impact the effectiveness of financial incentives intended to encourage primary care providers to improve patient experiences.

In the keynote presentation at Patient-Centered Diabetes Care 2015, Robert A. Gabbay, MD, PhD, discusses how new payment models can improve care in both type 1 and type 2 diabetes.

Just as diabetes care started the movement toward population management, it is leading the way to new payment models, according to speakers who appeared at a symposium to open the 75th Scientific Sessions of the American Diabetes Association.

New Jersey lawmakers want physicians to accept in-network rates if patients use their in-network hospital in an emergency. Other disputes would go to arbitration.

This is the third year that CMS has released Medicare payment data, and this year the agency added information on prescription drugs.

While the clinical data presented at the annual meeting of the American Society of Clinical Oncology (ASCO) created waves, a session on value had an equally significant impact as oncologists thronged to hear stakeholder voices define this, as yet abstract, concept of "value" in cancer care. The session brought together a patient representative, an oncologist, an ASCO representative, and a payer.